Trial intelligence / Profile preview

Desvenlafaxine SR in Fibromyalgia

NCT00696787Phase 2Terminated

Sponsor
Pfizer
Start
Jun 2008
Primary completion
Jan 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of desvenlafaxine in fibromyalgia (FM), sponsored by Pfizer. Started Jun 2008; status: terminated.

02

Drugs

desvenlafaxine
03

Conditions

fibromyalgia (FM)

Beyond the preview

Go deeper on NCT00696787.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00696787.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call